Skip to content

The prevalence and occurrence of sleep apnea syndrome in head and neck tumor patients: the efficacy of pre- and posttreatment.

The prevalence and occurrence of sleep apnea syndrome in head and neck tumor patients: the efficacy of pre- and posttreatment. - Sleep apnea syndrome in head and neck tumor patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032070
Enrollment
50
Registered
2018-04-02
Start date
2017-05-01
Completion date
Unknown
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck tumor and sleep apnea syndrome.

Interventions

Sponsors

Juntendo University
Lead Sponsor
Juntendo Urayasu Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: Patients who die during the study period.

Design outcomes

Primary

MeasureTime frame
This is prospective study for 12 months-follow-up. Nasopharyngeal scope, blood tests, rhinometry and polysomnography are planned.

Countries

Japan

Contacts

Public ContactAyako Inoshita

Juntendo University School of Medicine, Juntendo Hospital Otorhinolaryngology, Head and Neck Surgery

ayaent@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026